Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #68
- Final score
- 67.36
- Years on list
- 6
↗ Climbed 352 since 2021
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 352 since 2021
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 47 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 177 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | VTRS | MRK | MTD |
|---|---|---|---|
| Climate Change | 81.8 | 75.3 | 85.5 |
| Employee Relations | 56.0 | 61.2 | 53.6 |
| Environment | 71.3 | 64.0 | 70.0 |
| Stakeholders & Society | 75.5 | 69.6 | 68.1 |
| Human Rights | 51.2 | 76.1 | 49.7 |
| Governance | 55.0 | 57.5 | 62.3 |
| Performance Rating | 70.2 | 73.1 | 59.6 |